Read + Share
Amedeo Smart
Independent Medical Education
Desai M, Cardona J, Khetan S, Mehta S, et al. Safety and immunogenicity of mRNA-1345 revaccination at least 12 months following primary vaccination with a licensed protein subunit RSV vaccine. Vaccine 2026;92:129068.PMID: 42710149
Email
LinkedIn
Privacy Policy